Dr. Dugan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8111 S Emerson Ave
# 105
Indianapolis, IN 46237Phone+1 317-528-5500Fax+1 317-528-6316
Education & Training
University of MinnesotaFellowship, Hematology and Medical Oncology, 1992 - 1995
Indiana University School of MedicineResidency, Internal Medicine, 1989 - 1992- Indiana University School of MedicineClass of 1989
Certifications & Licensure
IN State Medical License 1990 - 2025
MN State Medical License 1992 - 1995
Clinical Trials
Publications & Presentations
PubMed
- 22 citationsBarriers to Physician Adherence to Evidence-Based Monitoring Guidelines in Chronic Myelogenous LeukemiaStuart L. Goldberg, Luke P. Akard, Michael J. Dugan, Stefan Faderl, Andrew L. Pecora
Journal of Oncology Practice. 2015-05-01 - 102 citationsSafety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with mult...Michael J. Dugan, Richard T. Maziarz, William I. Bensinger, A P Nademanee, Jane L. Liesveld
Bone Marrow Transplantation. 2010-01-01 - 100 citationsLong-Term Side Effects of Tyrosine Kinase Inhibitors in Chronic Myeloid LeukemiaLauren E. Caldemeyer, Michael J. Dugan, John G. Edwards, Luke P. Akard
Current Hematologic Malignancy Reports. 2016-02-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
